Curcumin attenuates vascular inflammation and cerebral vasospasm after subarachnoid hemorrhage in mice

Chandramohan Wakade, Melanie D. King, Melissa D. Laird, Cargill H. Alleyne, Krishnan M. Dhandapani

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Cerebral vasospasm is a major cause of death and disability after subarachnoid hemorrhage (SAH); however, clinical therapies to limit the development of cerebral vasospasm are lacking. Although the causative factors underlying the development of cerebral vasospasm are poorly understood, oxidative stress contributes to disease progression. In the present study, curcumin (150 or 300 mg/kg) protected against the development of cerebral vasospasm and limited secondary cerebral infarction after SAH in mice. The protective effect of curcumin was associated with a significant attenuation of inflammatory gene expression and lipid peroxidation within the cerebral cortex and the middle cerebral artery. Despite the ability of curcumin to limit the development of cerebral vasospasm and secondary infarction, behavioral outcome was not improved, indicating a dissociation between cerebral vasospasm and neurologic outcome. Together, these data indicate a novel role for curcumin as a possible adjunct therapy after SAH, both to prevent the development of cerebral vasospasm and to reduce oxidative brain injury after secondary infarction.

Original languageEnglish (US)
Pages (from-to)35-45
Number of pages11
JournalAntioxidants and Redox Signaling
Volume11
Issue number1
DOIs
StatePublished - Jan 1 2009

Fingerprint

Intracranial Vasospasm
Curcumin
Subarachnoid Hemorrhage
Blood Vessels
Inflammation
Oxidative stress
Infarction
Gene expression
Brain
Lipids
Cerebral Infarction
Middle Cerebral Artery
Cerebral Cortex
Brain Injuries
Nervous System
Lipid Peroxidation
Disease Progression
Cause of Death
Oxidative Stress
Gene Expression

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Molecular Biology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Curcumin attenuates vascular inflammation and cerebral vasospasm after subarachnoid hemorrhage in mice. / Wakade, Chandramohan; King, Melanie D.; Laird, Melissa D.; Alleyne, Cargill H.; Dhandapani, Krishnan M.

In: Antioxidants and Redox Signaling, Vol. 11, No. 1, 01.01.2009, p. 35-45.

Research output: Contribution to journalArticle

@article{8f70dd62ae834650a3a3d891f816c382,
title = "Curcumin attenuates vascular inflammation and cerebral vasospasm after subarachnoid hemorrhage in mice",
abstract = "Cerebral vasospasm is a major cause of death and disability after subarachnoid hemorrhage (SAH); however, clinical therapies to limit the development of cerebral vasospasm are lacking. Although the causative factors underlying the development of cerebral vasospasm are poorly understood, oxidative stress contributes to disease progression. In the present study, curcumin (150 or 300 mg/kg) protected against the development of cerebral vasospasm and limited secondary cerebral infarction after SAH in mice. The protective effect of curcumin was associated with a significant attenuation of inflammatory gene expression and lipid peroxidation within the cerebral cortex and the middle cerebral artery. Despite the ability of curcumin to limit the development of cerebral vasospasm and secondary infarction, behavioral outcome was not improved, indicating a dissociation between cerebral vasospasm and neurologic outcome. Together, these data indicate a novel role for curcumin as a possible adjunct therapy after SAH, both to prevent the development of cerebral vasospasm and to reduce oxidative brain injury after secondary infarction.",
author = "Chandramohan Wakade and King, {Melanie D.} and Laird, {Melissa D.} and Alleyne, {Cargill H.} and Dhandapani, {Krishnan M.}",
year = "2009",
month = "1",
day = "1",
doi = "10.1089/ars.2008.2056",
language = "English (US)",
volume = "11",
pages = "35--45",
journal = "Antioxidants and Redox Signaling",
issn = "1523-0864",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Curcumin attenuates vascular inflammation and cerebral vasospasm after subarachnoid hemorrhage in mice

AU - Wakade, Chandramohan

AU - King, Melanie D.

AU - Laird, Melissa D.

AU - Alleyne, Cargill H.

AU - Dhandapani, Krishnan M.

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Cerebral vasospasm is a major cause of death and disability after subarachnoid hemorrhage (SAH); however, clinical therapies to limit the development of cerebral vasospasm are lacking. Although the causative factors underlying the development of cerebral vasospasm are poorly understood, oxidative stress contributes to disease progression. In the present study, curcumin (150 or 300 mg/kg) protected against the development of cerebral vasospasm and limited secondary cerebral infarction after SAH in mice. The protective effect of curcumin was associated with a significant attenuation of inflammatory gene expression and lipid peroxidation within the cerebral cortex and the middle cerebral artery. Despite the ability of curcumin to limit the development of cerebral vasospasm and secondary infarction, behavioral outcome was not improved, indicating a dissociation between cerebral vasospasm and neurologic outcome. Together, these data indicate a novel role for curcumin as a possible adjunct therapy after SAH, both to prevent the development of cerebral vasospasm and to reduce oxidative brain injury after secondary infarction.

AB - Cerebral vasospasm is a major cause of death and disability after subarachnoid hemorrhage (SAH); however, clinical therapies to limit the development of cerebral vasospasm are lacking. Although the causative factors underlying the development of cerebral vasospasm are poorly understood, oxidative stress contributes to disease progression. In the present study, curcumin (150 or 300 mg/kg) protected against the development of cerebral vasospasm and limited secondary cerebral infarction after SAH in mice. The protective effect of curcumin was associated with a significant attenuation of inflammatory gene expression and lipid peroxidation within the cerebral cortex and the middle cerebral artery. Despite the ability of curcumin to limit the development of cerebral vasospasm and secondary infarction, behavioral outcome was not improved, indicating a dissociation between cerebral vasospasm and neurologic outcome. Together, these data indicate a novel role for curcumin as a possible adjunct therapy after SAH, both to prevent the development of cerebral vasospasm and to reduce oxidative brain injury after secondary infarction.

UR - http://www.scopus.com/inward/record.url?scp=55249104098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55249104098&partnerID=8YFLogxK

U2 - 10.1089/ars.2008.2056

DO - 10.1089/ars.2008.2056

M3 - Article

C2 - 18752423

AN - SCOPUS:55249104098

VL - 11

SP - 35

EP - 45

JO - Antioxidants and Redox Signaling

JF - Antioxidants and Redox Signaling

SN - 1523-0864

IS - 1

ER -